Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - trimethoprim, sulfamethoxazole - tablet - trimethoprim 80 mg sulfamethoxazole 400 mg - antibacterials for systemic use

United States - English - NLM (National Library of Medicine)

lucid pharma llc - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - sulfamethoxazole 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination.

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - suspension - 80mg/400 mg per 5 ml - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci.(p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infections; acute otitis media; acute exacerbation of chronic bronchitis

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - suspension - 40mg/200mg per 5ml - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis treatment and prophylaxis of toxoplasmosis treatment of nocardiosis acute uncomplicated urinary tract infection acute otitis media acute exacerbation of chronic bronchitis

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 800mg/160mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 80mg/400mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 80 mg in 1 ml - sulfamethoxazole and trimethoprim injection is indicated in the treatment of pneumocystis jirovecii pneumonia in adults and pediatric patients two months of age and older. sulfamethoxazole and trimethoprim injection is indicated in the treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei in adults and pediatric patients two months of age and older. sulfamethoxazole and trimethoprim injection is indicated in the treatment of severe or complicated urinary tract infections in adults and pediatric patients two months of age and older due to susceptible strains of escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris when oral administration of sulfamethoxazole and trimethoprim injection is not feasible and when the organism is not susceptible to single-agent antibacterials effective in the urinary tract. to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxa

United States - English - NLM (National Library of Medicine)

mylan institutional llc - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 80 mg in 1 ml - sulfamethoxazole and trimethoprim injection is indicated in the treatment of pneumocystis jirovecii pneumonia in adults and pediatric patients two months of age and older. sulfamethoxazole and trimethoprim injection is indicated in the treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei in adults and pediatric patients two months of age and older. sulfamethoxazole and trimethoprim injection is indicated in the treatment of severe or complicated urinary tract infections in adults and pediatric patients two months of age and older due to susceptible strains of escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris when oral administration of sulfamethoxazole and trimethoprim injection is not feasible and when the organism is not susceptible to single-agent antibacterials effective in the urinary tract. to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethox

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - trimethoprim; sulfamethoxazole - oral tablet - 160mg ; 800mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - trimethoprim; sulfamethoxazole - oral suspension - 16mg/1ml ; 80mg/1ml